Lv7
4380 积分 2023-06-27 加入
纯合子家族性高胆固醇血症早期筛查与管理中国专家共识（2024年）
5天前
已完结
The evolving landscape of obesity pharmacotherapy
6天前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
6天前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
6天前
已完结
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia
7天前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
9天前
已完结
A dose–response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality
9天前
已完结
Fibroblast activation and heterogeneity in fibrotic disease
12天前
已完结
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies
14天前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
14天前
已完结
皖公网安备34019202002308
